CDC14A and fungal infectious disease: In mammals, current evidence based on KO mice suggest that it is not required for normal postnatal growth and development (21), and other reported phenotypes associated with loss of Cdc14 function support that side effects associated with temporary inhibition to prevent or treat an invasive fungal infection might be minimal (14, 16, 19, 61).